SCHEMBL30856077

SCHEMBL30856077

Cc1c([N+](=O)[O-])cc2[nH]ncc2c1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.51
▸ NOS1 P29475 4/20 0.50
▸ PIM3 Q86V86 5/20 0.48
▸ PIM1 P11309 2/20 0.48
▸ TDO2 P48775 8/20 0.45
▸ IDO1 P14902 6/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 3/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ APEX1 P27695 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14718665 0.80 PIM3 (0.50) NOS1PIM3PIM1TDO2IDO1
SCHEMBL31217276 0.78 CYP1A2 (0.51) CYP1A2NOS1PIM3PIM1TDO2
SCHEMBL30410207 0.78 IDO1 (0.47) CYP1A2NOS1TDO2IDO1
SCHEMBL19948646 0.78 IDO1 (0.47) CYP1A2NOS1TDO2IDO1
SCHEMBL4400129 0.78 NOS1 (0.57) NOS1PIM3PIM1TDO2IDO1
SCHEMBL1250107 0.78 NOS1 (0.57) NOS1PIM3PIM1TDO2IDO1
SCHEMBL21271929 0.78 NOS1 (0.61) CYP1A2NOS1PIM3PIM1TDO2
SCHEMBL2571809 0.74 NOS1 (0.61) CYP1A2NOS1PIM3PIM1TDO2
SCHEMBL21196262 0.73 IDO1 (0.47) NOS1TDO2IDO1
SCHEMBL21379129 0.73 TDO2 (0.43) CYP1A2NOS1PIM3TDO2IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120152713-A Tricyclic aryl derivatives and compositions and methods thereof 昂胜医疗科技公司 2025-06-13 — — CN disclosed
EP-4561562-A2 TRICYCLIC ARYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF Ensem Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2024026128-A2 TRICYCLIC ARYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback